Immunoprecipitation Market Size, Share, Trends Analysis and Growth Forecast
The global immunoprecipitation market is expected to exhibit a solid 5.2% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). Immunoprecipitation is becoming increasingly important in the life sciences sector, leading to a growing demand for immunoprecipitation processes and objects. The market is expected to rise to a valuation of USD 562 million by 2023, according to the MRFR report.
The rising prevalence of autoimmune disorders is a major driver for the global immunoprecipitation market, as antigen identification is a major process in curing autoimmune disorders. Various environmental factors have led to a growing prevalence of autoimmune disorders, while people are also more aware of autoimmune disorders than ever before. This has led to a growing demand for processes used to identify and cure autoimmune disorders.
The growing life sciences sector is also a major driver for the global immunoprecipitation market. The life sciences sector has become a prime target for investment from healthcare industry giants due to the growing financial prospects of the healthcare industry. Governments have also invested in a major way in the life sciences sector due to the growing demand for population health programs and the rising demand for effective cures for infectious and noninfectious diseases. The rising demand for personalized therapeutics is also likely to be a major driver for the global immunoprecipitation market over the forecast period.
Competitive Leaderboard:
Leading players in the global immunoprecipitation market include Abcam plc, GenScript, Thermo Fisher Scientific, Bio-Rad Laboratories Inc., Merck KGaA, BioLegend Inc., Takara Bio Inc., Rockland Immunochemicals Inc., Cell Signaling Technology Inc., and Geno Technology Inc.
Segmentation:
The global immunoprecipitation market has been segmented on the basis of type, product, end user, and region.
The immunoprecipitation market, on the basis of type, has been segmented into individual immunoprecipitation, co-immunoprecipitation, chromatin immunoprecipitation, and RNA immunoprecipitation.
The market, by product type, has been segmented into kit, reagent, and others. The reagent segment has been further segmented into antibodies and beads. Antibodies are further segmented into primary and secondary. Beads are further segmented into agarose beads, magnetic beads, and buffers.
The market, by end user, has been segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, and others.
Regional Analysis:
The Americas hold the largest share in the global immunoprecipitation market due to the strong position of the life sciences sector in the region. The healthcare industry is strong in the U.S. and Canada, which leads to a strong demand for product and technological advancement in the region. The growing prevalence of autoimmune disorders in the region is also a key driver for the global immunoprecipitation market.
Europe holds the second largest share in the global immunoprecipitation market, followed by Asia Pacific. The latter is expected to exhibit the fastest growth rate over the forecast period due to the growing investment in the healthcare sector in the region.
Read More:https://www.marketresearchfuture.com/reports/immunoprecipitation-market-7816